Science and Health

  • Science and Health
  • There’s a lot of life science content out there, which is why we’ve curated a selection of our expert insights, tips, case studies, and scientific and regulatory information for your convenience. Catch up on what you might have missed below!

    Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues. In this blog article, we review some of these areas of investigation where Altasciences has robust expertise and solution offerings.

     

    Altasciences' Truly Integrated Platform

    Your Audiobook Release Recap Has Arrived


     

    Listen to the Latest Audiobook Releases of The Altascientist

    Delve deeper into the critical processes behind early phase drug development with audio versions of The Altascientist, written by our experts with you in mind:

    Issue 34 — Toxicokinetics, Pharmacokinetics, and Pharmacodynamics
    Take a closer look at the collection and use of a novel drug's PK/PD data in early phase drug development, and why this data is critical to setting up your clinical trials.
    Listen to the audiobook >>>

    Issue 35 — Critical Considerations for the Compliant Manufacture of Highly Potent Drugs
    Learn how facilities, equipment, and processes for HPAPIs should be adapted to maximize safety and success for your development projects.
    Listen to the audiobook >>>​​​

    Issue 36 — Nonclinical Studies in Cell and Gene Therapy
    Discover expert approaches to mitigating complex challenges, improving study efficiency, and maximizing translational opportunities to first-in-human trials.
    Listen to the audiobook >>>

    Issue 37 — Quantitative PCR (qPCR) and Droplet Digital (ddPC)
    Foster a more comprehensive understanding of PCR and discover a more sophisticated approach to data analysis and experimentation.
    Listen to the audiobook >>>

    SPEAK WITH AN EXPERT

    VISIT THE FULL LIBRARY

     

    There’s a lot of life science content out there, which is why we’ve curated a selection of our expert insights, tips, case studies, and scientific and regulatory information for you. Catch up on what you may have missed below!

    Top 10 Life Science Resources - October 2023

    Altasciences
     

    Top 10 Life Science Resources 

    Your time is precious. Therefore, we’ve curated a selection of recently published expert insights, tips, case studies, and scientific and regulatory information, just for you. 

    1. eBook: Safety Assessment for Ophthalmic Products

      Learn about the considerations and assessments necessary for performing nonclinical research on ophthalmic therapies, from species selection and routes of administration to preparing for first-in-human trials. Read it now.
       
    2. ​​The Altascientist: Issue No. 36 – Nonclinical Studies in Cell and Gene Therapy: Key Considerations and Regulatory Guidance

      Find out what the key factors are when developing nonclinical cell and gene therapies–including expert approaches to mitigating complex challenges, improving study efficiency, and maximizing translational opportunities to first-in-human (FIH) trials.​​​​​ Read or listen now.
    1. Video: Think Canada: The Team Behind Your Clinical Trials

      Learn about the inner workings of our clinical pharmacology unit in Montréal, and meet the dedicated team of experts driving the many trials conducted there, in this fun behind-the-scenes look. Watch the video.
       
    2. Podcast: FDA Guidance for Industry Psychedelic Drugs

      Listen to an in-depth discussion on the FDA’s recent draft guidance on clinical investigation of psychedelic drugs with Altasciences’ expert doctors, Denise Milovan, Debra Kelsh, and Beatrice Setnik. Listen to the podcast.
    1. Fact Sheet: Bioanalytical Expertise for Immunomodulatory Drugs 

      See how Altasciences’ bioanalytical experts can provide support for your immunomodulatory drugs, and advance your drugs from preclinical to early phase clinical trials.​​​​​ Read the fact sheet.
       
    2. Blog: Choosing the Best Bioanalytical Platform for Your Program

      Explore how we determine the most appropriate and effective bioanalytical platform for your molecule. Read the blog.
      ​​​
    1. The Altascientist: Issue No. 35 – Critical Considerations for the Safe and Compliant Manufacture of Highly Potent Drugs

      How the demand for manufacturing highly potent active pharmaceutical ingredients (HPAPIs) has increased, and the intricacies involved in manufacturing them safely. Read or listen now.
       
    2. Podcast: Successful Manufacturing of Clinical Trial Supply

      Uncover secrets from our formulation and pharmacy experts for effectively completing clinical trials, and resolving potential issues that could hinder your drug development timeline. Listen here.
    1. Educational Video: The Benefits of Conducting a Clinical Trial in Canada

      Gain valuable insights into Health Canada's Clinical Trial Application (CTA) submission and review process, along with answers to some of your most common questions. Watch it now.
       
    2. The Altascientist: Issue No. 34: Toxicokinetics, Pharmacokinetics, and Pharmacodynamics 

      Take a closer look at the collection and use of pharmacokinetic (PK) and pharmacodynamic (PD) data in early phase drug development, as well as the critical role of nonclinical toxicokinetic (TK) studies in guiding early phase clinical trials. Read or listen now.
    Visit Our Complete Resource Center

    Recent Regulatory Updates:

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

     

     

     

     

     

     

     

    Getting to the Heart of Science with Amber malloy

    Amber Malloy, Analytical Associate III, Altasciences
    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Opinion | A Day to Celebrate, and a Call to Action

    Dr.

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Opioids are highly effective at relieving both acute and chronic pain. However, this benefit comes at a significant cost: they are also highly addictive.

    .left {float:left; width:60%; margin-right:1rem; padding-top:1rem;} .right {float:left; width:35%; padding-top:1rem;} @media only screen and (max-width: 960px) { .left {float:none; width:100%;} .right {float:none; width:100%;} }

    PCR testing has been in the spotlight as the most reliable way of screening for COVID-19 in patients since the beginning of the pandemic. But what is PCR? And what are its other uses?

    Subscribe to Science and Health